State Street Corp Kintara Therapeutics, Inc. Transaction History

State Street Corp

  • $2.25 Trillion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
BUY
$0.82 - $2.3 $6,642 - $18,630
8,100 Added 7.5%
116,074 $100,000
Q2 2021

Aug 16, 2021
BUY
$1.26 - $2.4 $118,785 - $226,257
94,274 Added 688.13%
107,974 $245,000
Q3 2020

Nov 10, 2020
BUY
$0.63 - $1.7 $8,631 - $23,290
13,700 New
13,700 $19,000

About Kintara Therapeutics, Inc.

KTRA Quotes by TradingView
  • Ticker KTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,807,296
  • Market Cap $17.8M
  • Description
  • Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme,...
More about KTRA
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email